510(k) K992662
K992662 is an FDA 510(k) premarket notification submitted by Bayer Corp. for the device "8 ADDITIONAL ASSAYS FOR THE BAYER ADVIA 1650 CHEMISTRY SYSTEM". The FDA issued a decision of Substantially Equivalent on February 15, 2000. The device falls under product code MSJ (Apolipoproteins), a Class I device regulated under 21 CFR 862.1475. Bayer Corp. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- February 15, 2000
- Date Received
- August 9, 1999
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Apolipoproteins
- Device Class
- Class I
- Regulation Number
- 862.1475
- Review Panel
- CH
- Submission Type